Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings

Table 1 Clinical features of hepatoid adenocarcinoma of the stomach

Case No.	Sex/age (yr)	Initial presentation	Location(largest size, cm)	Metastasis	Serum AFP(ng/mL)	Treatment	Follow-up status
1	M/64	Epigastric discomfort	Body, antrum (7.5)	Liver	1133.7	Gastrectomy	Died at 19 mo
				Peritoneum		Chemotherapy
				Perigastric lymph nodes		TACE for liver metastases
2	M/69	Body weight loss	Antrum (7.3)	Liver	281.1	Gastrectomy	Died at 3 mo
				Lung		Chemotherapy
3	M/78	Epigastric discomfort	Antrum (4.5)	Liver	3124.9	Gastrectomy	Died at 5 mo
				Perigastric lymph nodes		Chemotherapy
4	M/63	Epigastric discomfort	Cardia (5.2)	Liver	2170.3	Chemotherapy	Died at 6 mo
				Peritoneum		TACE for liver metastases
				Perigastric lymph nodes
5	F/70	Palpable mass	Body, antrum (3.8)	Liver	890.3	Chemotherapy	Died at 23 mo
				Perigastric lymph nodes		TACE for liver metastases
6	F/69	Epigastric discomfort	Body, antrum (7.5)	Liver	6442.6	Chemotherapy	Died at 9 mo
				Perigastric lymph nodes
7	M/60	Epigastric discomfort	Antrum (4.5)	Liver	1419.7	Chemotherapy	Died at 3 mo
				Peritoneum
				Paraaortic lymph nodes
				Perigastric lymph nodes
8	M/75	Body weight loss	Body (4.0)	Liver	2904.5	Supportive care	Died at 3 mo
				Lung
				Peritoneum
				Perigastric lymph nodes

M: Male; F: Female; AFP: Alpha-fetoprotein; TACE: Transarterial chemoembolization.